Clinical trial
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee…
NCT00486434 · Nordic Bioscience A/S, Industry · Completed
Key facts
| NCT number | NCT00486434 |
|---|---|
| Title | Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis |
| Official title | A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Subjects With Knee Osteoarthritis |
| Lead sponsor | Nordic Bioscience A/S, Industry |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | SMC021 Oral Calcitonin, SMC021 Placebo |
| Enrollment | 1,176 |
| Start date | May 1, 2007 |
| Primary completion | Sep 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Jun 14, 2007 |
| Last update posted | Apr 26, 2019 |
| Countries | Czechia, Denmark, Estonia, Hong Kong, Poland, Romania |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: